Literature DB >> 5935363

Double isotope dilution derivative assay of digitoxin in plasma, urine, and stool of patients maintained on the drug.

D A Lukas, R E Peterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5935363      PMCID： PMC292755          DOI： 10.1172/JCI105393

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  39 in total

1.  Evidence that a humoral agent stimulates the adrenal cortex to secrete aldosterone in experimental secondary hyperaldosteronism.

Authors:  N A YANKOPOULOS; J O DAVIS; B KLIMAN; R E PETERSON; A CASPER
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  ENZYMATIC BASIS FOR EPIMERIZATION OF CARDIOTONIC STEROIDS AT CARBON 3 IN RAT LIVER.

Authors:  K REPKE; L T SAMUELS
Journal:  Biochemistry       Date:  1964-05       Impact factor: 3.162

3.  The excretory products of lanatoside C and digitoxin in the rat.

Authors:  B T BROWN; D RANGER; S E WRIGHT
Journal:  J Pharmacol Exp Ther       Date:  1955-03       Impact factor: 4.030

4.  Blood level studies of C14-digitoxin in human subjects with cardiac failure.

Authors:  G T OKITA; P J TALSO; J H CURRY; F D SMITH; E M GEILING
Journal:  J Pharmacol Exp Ther       Date:  1955-04       Impact factor: 4.030

5.  Subcellular localization of radioactive digitoxin.

Authors:  J L SPRATT; G T OKITA
Journal:  J Pharmacol Exp Ther       Date:  1958-10       Impact factor: 4.030

6.  Metabolic fate of radioactive digitoxin in human subjects.

Authors:  G T OKITA; P J TALSO; J H CURRY; F D SMITH; E M GEILING
Journal:  J Pharmacol Exp Ther       Date:  1955-12       Impact factor: 4.030

7.  Colorimetric estimation of digitalis glycosides with 2:4-dinitrodiphenylsulphone.

Authors:  D H TATTJE
Journal:  J Pharm Pharmacol       Date:  1958-08       Impact factor: 3.765

8.  Biosynthesis of Radioactive Drugs Using Carbon 14.

Authors:  E M Geiling; F E Kelsey; B J McIntosh; A Ganz
Journal:  Science       Date:  1948-11-19       Impact factor: 47.728

9.  Fluorimetric determination of gitoxigenin.

Authors:  K B JENSEN
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1952

10.  Paper-chromatographic separation and fluorimetric determination of gitoxigenin, gitoxin, and purpureaglycoside B.

Authors:  K B JENSEN
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1952
View more
  27 in total

1.  Clinical pharmacokinetics of digitoxin.

Authors:  D Perrier; M Mayersohn; F I Marcus
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

2.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

Review 3.  [Determination of digoxin and digitoxin in the blood and their clinical significance].

Authors:  G Bodem; H J Gilfrich
Journal:  Klin Wochenschr       Date:  1973-01-15

4.  Physiological distribution of digoxin in human heart.

Authors:  D J Coltart; H G Güllner; M Billingham; R H Goldman; E B Stinson; S M Kalman; D C Harrison
Journal:  Br Med J       Date:  1974-12-28

5.  Human plasma digoxin levels.

Authors:  P F Binnion
Journal:  Ir J Med Sci       Date:  1974-01       Impact factor: 1.568

6.  Plasma concentrations of cardiac glycosides in digitalis intoxication.

Authors:  G Somogyi; A Káldor; A Jankovics
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

7.  [Dialysis and per cent elimination of different cardiac glycosides during haemo- and peritonealdialysis].

Authors:  P Kramer; E Quellhorst; J Horenkamp; F Scheler
Journal:  Klin Wochenschr       Date:  1972-06-15

Review 8.  Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Authors:  P Kramer
Journal:  Klin Wochenschr       Date:  1977-01-01

9.  Metabolism of digitoxin in man and its modification by spironolactone.

Authors:  K E Wirth; J C Frölich; J W Hollifield; F C Falkner; B S Sweetman; J A Oates
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

10.  Ouabain-specific antibodies: immunochemical properties and reversal of Na + , K + -activated adenosine triphosphatase inhibition.

Authors:  T W Smith
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.